TY - JOUR
T1 - Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stains
AU - The Nephrotic Syndrome Study Network (NEPTUNE)
AU - Jayapandian, Catherine P.
AU - Chen, Yijiang
AU - Janowczyk, Andrew R.
AU - Palmer, Matthew B.
AU - Cassol, Clarissa A.
AU - Sekulic, Miroslav
AU - Hodgin, Jeffrey B.
AU - Zee, Jarcy
AU - Hewitt, Stephen M.
AU - O'Toole, John
AU - Toro, Paula
AU - Sedor, John R.
AU - Barisoni, Laura
AU - Madabhushi, Anant
AU - Dell, K.
AU - Schachere, M.
AU - Negrey, J.
AU - Lemley, K.
AU - Lim, E.
AU - Srivastava, T.
AU - Garrett, A.
AU - Sethna, C.
AU - Laurent, K.
AU - Appel, G.
AU - Toledo, M.
AU - Barisoni, L.
AU - Greenbaum, L.
AU - Wang, C.
AU - Kang, C.
AU - Adler, S.
AU - Nast, C.
AU - LaPage, J.
AU - Stroger, John H.
AU - Athavale, A.
AU - Itteera, M.
AU - Neu, A.
AU - Boynton, S.
AU - Fervenza, F.
AU - Hogan, M.
AU - Lieske, J.
AU - Chernitskiy, V.
AU - Kaskel, F.
AU - Kumar, N.
AU - Flynn, P.
AU - Kopp, J.
AU - Blake, J.
AU - Trachtman, H.
AU - Zhdanova, O.
AU - Modersitzki, F.
AU - Vento, S.
N1 - Funding Information:
Research reported in this publication was supported by the following awards: Case Western Reserve University (CWRU) Nephrology Training Grant (5T32DK007470-34); NephCure Kidney International/NEPTUNE pilot study and by the NephCure/Smokler Gift to Duke University; The KidneyCure, ASN Foundation; National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01 , R01CA202752-01A1 , R01CA208236-01A1 , R01 CA216579-01A1 , R01 CA220581-01A1 , and 1U01 CA239055-01 ; National Institute of Biomedical Imaging and Bioengineering 1R43EB028736-01 ; National Center for Research Resources under award number 1 C06 RR12463-01 ; VA Merit Review Award IBX004121A from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service; the Department of Defense (DOD) Breast Cancer Research Program Breakthrough Level 1 Award W81XWH-19-1-0668; the DOD Prostate Cancer Idea Development Award (W81XWH-15-1-0558); the DOD Lung Cancer Investigator-Initiated Translational Research Award (W81XWH-18-1-0440); the DOD Peer Reviewed Cancer Research Program (W81XWH-16-1-0329); the Ohio Third Frontier Technology Validation Fund; and the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering and the Clinical and Translational Science Award Program at Case Western Reserve University.
Funding Information:
JZ reports grants from NephCure Kidney International during the conduct of the study. JRS reports grants from National Institute of Diabetes and Digestive and Kidney Diseases and from NephCure Kidney International during the conduct of the study. Dr. Madabhushi reports work with Inspirata Inc., Bristol Myers Squibb, Philips, Astrazeneca, Aiforia, and Elucid Bioimaging and grants form PathCore Inc. and Diascopic Inc., all outside the submitted work. All the other authors declared no competing interests.
Funding Information:
Research reported in this publication was supported by the following awards: Case Western Reserve University (CWRU) Nephrology Training Grant (5T32DK007470-34); NephCure Kidney International/NEPTUNE pilot study and by the NephCure/Smokler Gift to Duke University; The KidneyCure, ASN Foundation; National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01, R01CA202752-01A1, R01CA208236-01A1, R01 CA216579-01A1, R01 CA220581-01A1, and 1U01 CA239055-01; National Institute of Biomedical Imaging and Bioengineering 1R43EB028736-01; National Center for Research Resources under award number 1 C06 RR12463-01; VA Merit Review Award IBX004121A from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service; the Department of Defense (DOD) Breast Cancer Research Program Breakthrough Level 1 Award W81XWH-19-1-0668; the DOD Prostate Cancer Idea Development Award (W81XWH-15-1-0558); the DOD Lung Cancer Investigator-Initiated Translational Research Award (W81XWH-18-1-0440); the DOD Peer Reviewed Cancer Research Program (W81XWH-16-1-0329); the Ohio Third Frontier Technology Validation Fund; and the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering and the Clinical and Translational Science Award Program at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the U.S. Department of Veterans Affairs, the Department of Defense, or the U.S. Government.
Publisher Copyright:
© 2020 International Society of Nephrology
PY - 2021/1
Y1 - 2021/1
N2 - The application of deep learning for automated segmentation (delineation of boundaries) of histologic primitives (structures) from whole slide images can facilitate the establishment of novel protocols for kidney biopsy assessment. Here, we developed and validated deep learning networks for the segmentation of histologic structures on kidney biopsies and nephrectomies. For development, we examined 125 biopsies for Minimal Change Disease collected across 29 NEPTUNE enrolling centers along with 459 whole slide images stained with Hematoxylin & Eosin (125), Periodic Acid Schiff (125), Silver (102), and Trichrome (107) divided into training, validation and testing sets (ratio 6:1:3). Histologic structures were manually segmented (30048 total annotations) by five nephropathologists. Twenty deep learning models were trained with optimal digital magnification across the structures and stains. Periodic Acid Schiff-stained whole slide images yielded the best concordance between pathologists and deep learning segmentation across all structures (F-scores: 0.93 for glomerular tufts, 0.94 for glomerular tuft plus Bowman's capsule, 0.91 for proximal tubules, 0.93 for distal tubular segments, 0.81 for peritubular capillaries, and 0.85 for arteries and afferent arterioles). Optimal digital magnifications were 5X for glomerular tuft/tuft plus Bowman's capsule, 10X for proximal/distal tubule, arteries and afferent arterioles, and 40X for peritubular capillaries. Silver stained whole slide images yielded the worst deep learning performance. Thus, this largest study to date adapted deep learning for the segmentation of kidney histologic structures across multiple stains and pathology laboratories. All data used for training and testing and a detailed online tutorial will be publicly available.
AB - The application of deep learning for automated segmentation (delineation of boundaries) of histologic primitives (structures) from whole slide images can facilitate the establishment of novel protocols for kidney biopsy assessment. Here, we developed and validated deep learning networks for the segmentation of histologic structures on kidney biopsies and nephrectomies. For development, we examined 125 biopsies for Minimal Change Disease collected across 29 NEPTUNE enrolling centers along with 459 whole slide images stained with Hematoxylin & Eosin (125), Periodic Acid Schiff (125), Silver (102), and Trichrome (107) divided into training, validation and testing sets (ratio 6:1:3). Histologic structures were manually segmented (30048 total annotations) by five nephropathologists. Twenty deep learning models were trained with optimal digital magnification across the structures and stains. Periodic Acid Schiff-stained whole slide images yielded the best concordance between pathologists and deep learning segmentation across all structures (F-scores: 0.93 for glomerular tufts, 0.94 for glomerular tuft plus Bowman's capsule, 0.91 for proximal tubules, 0.93 for distal tubular segments, 0.81 for peritubular capillaries, and 0.85 for arteries and afferent arterioles). Optimal digital magnifications were 5X for glomerular tuft/tuft plus Bowman's capsule, 10X for proximal/distal tubule, arteries and afferent arterioles, and 40X for peritubular capillaries. Silver stained whole slide images yielded the worst deep learning performance. Thus, this largest study to date adapted deep learning for the segmentation of kidney histologic structures across multiple stains and pathology laboratories. All data used for training and testing and a detailed online tutorial will be publicly available.
KW - computerized morphologic assessment
KW - deep learning
KW - digital pathology
KW - kidney histologic primitives
KW - large-scale tissue interrogation
KW - renal biopsy interpretation
UR - http://www.scopus.com/inward/record.url?scp=85098782306&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098782306&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2020.07.044
DO - 10.1016/j.kint.2020.07.044
M3 - Article
C2 - 32835732
AN - SCOPUS:85098782306
SN - 0085-2538
VL - 99
SP - 86
EP - 101
JO - Kidney international
JF - Kidney international
IS - 1
ER -